Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of life sciences equipment provider Waters
So what: Thanks to the addition of new life sciences products and not relying on U.S. government and university funding, Waters was able to handily surpass Wall Street's consensus estimates. For the quarter, Waters reported a profit $1.56 while sales rose 8% to $521.4 million. This compares favorably to the $1.50 in profit and $516.9 million that analysts had been looking for. Waters also provided first-quarter and full-year 2012 guidance that came in just slightly below what Wall Street had been expecting and noted that sales would be less robust in the coming fiscal year.
Now what: Waters' beat is great for the other big names in the life sciences instrumentation sector, but its disappointing forecast for 2012 indicates that growth is expected to slow in the U.S. and Japan. Everyone has been so busy focusing on U.S. government and university spending that they failed to notice that the worldwide economy is beginning to slow to a crawl. While I'm not overwhelmingly against owning Waters here, I also don't think there's a lot of value left to unlock in the stock with it already trading north of 16 times forward earnings, and I think you could do better looking elsewhere after today's pop.
Craving more input? Start by adding Waters to your free and personalized watchlist so you can keep up on the latest news with the company.